Overview

A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate pharmacokinetics and safety after oral administration of Irbesartan and Atorvastatin in combination as HCP0912

Phase:

Phase 1

Details

Lead Sponsor:

Hanmi Pharmaceutical Company Limited

Treatments:

Atorvastatin
Atorvastatin Calcium
Irbesartan